ArticleBiomedical microdevices2026
Transcriptomic profiling of radiopaque nanoparticle-loaded, bioresorbable polymeric perivascular wrap for arteriovenous fistula maturation.
Article in Biomedical microdevices, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Arteriovenous fistula (AVF) failure remains a significant clinical problem for hemodialysis access. It is driven by hemodynamic changes which promote inflammatory responses leading to neointimal hyperplasia and ultimately stenosis. Perivascular wraps have proved to be a promising intervention for mitigating hemodynamics stress. However, the molecular impact of perivascular wraps on the venous wall is not fully understood. This study aims to evaluate the molecular effects of polycaprolactone (PCL) perivascular wraps and PCL wraps embedded with radiopaque bismuth nanoparticles (PCL-Bi) on the outflow vein. Chronic kidney disease (CKD) was induced in female Sprague-Dawley rats through 5/6th nephrectomy. After CKD induction, AVFs were created via end-to-side anastomosis of the external jugular vein to the common carotid artery. The AVFs were treated with either a PCL wrap, a PCL-Bi wrap, or left as unwrapped controls (n = 3 each group). The outflow veins were harvested for bulk RNA sequencing after 8 weeks. Differential expression and pathway enrichment analyses were performed to evaluate differences between the groups. Compared to the unwrapped controls, the PCL-wrapped AVFs showed significant downregulation of pathways related to vascular smooth muscle cell processes, endothelial cell processes, and cell adhesion. Conversely, pathways related to phagocytosis and lysosomal activity were upregulated, reflecting a controlled response to the bioresorbable scaffold. Few differences were observed between the PCL and PCL-Bi wrapped AVFs, demonstrating that the addition of bismuth nanoparticles does not negate the beneficial effects of the PCL scaffold.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.